Next Article in Journal
Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer
Next Article in Special Issue
Using an Electromyography Method While Measuring Oxygen Uptake to Appreciate Physical Exercise Intensity in Adolescent Cyclists: An Analytical Study
Previous Article in Journal
A Case of Incidental Schwannoma Mimicking Necrotic Metastatic Lymph Node from Bladder Cancer
Previous Article in Special Issue
Training Load Measures and Biomarker Responses during a 7-Day Training Camp in Young Cyclists—A Pilot Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Acute Exhaustive Exercise under Normoxic and Normobaric Hypoxic Conditions Differentially Regulates Angiogenic Biomarkers in Humans

1
Exercise Physiology Research Group, Department of Movement Sciences, Biomedical Sciences Group, KU Leuven, 3000 Leuven, Belgium
2
The German Research Center of Elite Sport, German Sport University Cologne, 50933 Cologne, Germany
3
Institute of Cardiology and Sports Medicine, German Sport University Cologne, 50933 Cologne, Germany
4
Department of Sports Medicine and Sports Nutrition, Ruhr-University Bochum, 44801 Bochum, Germany
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(7), 727; https://doi.org/10.3390/medicina57070727
Submission received: 28 June 2021 / Accepted: 16 July 2021 / Published: 19 July 2021
(This article belongs to the Special Issue Muscle and Exercise Physiology)

Abstract

:
Background and Objectives: Angiogenesis describes the outgrowth of new capillaries from already existing ones. Different biomarkers regulate this process. Physical exercise and hypoxia are key stimuli for the activation of different angiogenic molecules, such as the vascular endothelial growth factor (VEGF). matrix metalloproteases (MMPs)-2 and -9 or the extracellular matrix cleavage fragment endostatin. The present study aimed to investigate influences of short-term, intensive cycling exercise under both normoxic and normobaric hypoxic conditions on the mentioned parameters. Materials and Methods: Twelve male subjects (age: 23.3 ± 2.0 years) participated in the study. All subjects conducted four intensive cycling tests until individual exhaustion in a randomized order under the following conditions: normoxia, 2000 m, 3000 m and 4000 m above sea level. Blood samples were taken before (pre) and 10 min, 30 min, 60 min and 240 min post exercise and were analyzed by ELISA. Results: VEGF showed a significantly reduced concentration compared to the pre-value solely under 4000 m at 10 min post exercise. MMP-2 showed significantly reduced concentrations at 240 min post exercise under 4000 m. MMP-9 increased at 240 min post exercise under both 2000 m and 4000 m conditions. Endostatin was significantly increased at 10 min post exercise independently of the applied stimulus. Conclusions: The presented data show that intensive short-term exercise bouts facilitate the bioavailability of angiogenic, ECM (extracellular matrix)-related biomarkers. This finding is interesting for both health- and performance-related research as it demonstrates the positive effects of intensive short exercise interventions.

1. Introduction

Physical exercise performance depends on the skeletal muscle tissue oxygen and nutrient support [1]. Consequently, the peripheral capillary bed plays a crucial role in the regulation of exercise capacities. The peripheral capillary bed possesses the capacity to increase in density through a process called angiogenesis, which characterizes the outgrowth of new capillaries for already existing ones [2]. This would result in a higher capillary-to-skeletal muscle fiber ratio with the consequence of enhanced endurance performance [3]. Furthermore, the acute regulation of the vascular permeability supports oxygen and nutrient support during acute exercise [3]. Finally, the acute adaptation of the vascular diameter through endothelial cell-derived nitric oxide (NO) is an important mechanism to supply working tissues, e.g., skeletal muscles under acute exercise [4].
A variety of blood-detectable biomarkers contributes to the regulation of the mentioned processes. Of note, the vascular endothelial growth factors (VEGF) is the most potent one to induce angiogenesis and vascular permeability [5]. Both processes receive support by the matrix metalloproteases (MMP), specifically MMP-2 and MMP-9, known as gelatinases [6]. The main functions of MMP-2 and MMP-9 in the periphery are the liberation of the growth factors stored in the extracellular matrix (ECM) [7,8]. This remodeling process involves the generation of ECM-derived cleavage fragments with biological properties [7]. One important cleavage fragment is endostatin, the NC1 domain-specific fragment of collagen XVIII, which is an endothelial cell-specific collagen [9]. Endostatin is actively involved in the acute control of the vascular diameter as it induces the generation of NO by activating the endothelial nitric oxide synthase (eNOS) [4]. Hence, VEGF, MMP-2, MMP-9 and endostatin are interesting biomarkers, whose acute regulations could give insights into performance-supporting mechanisms.
Our group demonstrated that both different exercise interventions [10,11] as well as changes in environmental conditions [10] challenge angiogenic modulators. However, it remains unclear, whether acute bouts of exhaustive exercise, as applied during athlete testing and in regular training cycles, change VEGF, MMP-2, MMP-9 and endostatin concentrations in the blood stream. To shed light on this interesting exercise physiology-related question, we subjected healthy young participants to a series of acute bouts of exhaustive exercise at normoxic (sea level), simulated hypoxia of 2000 m, 3000 m and 4000 m above sea level in a randomized order. We took blood samples at different time points at assess the concentrations of VEGF, MMP-2, MMP-9 and endostatin.

2. Materials and Methods

2.1. Subjects

Twelve male subjects (age: 23.3 ± 2.0 years, height: 181.1 ± 6.2 cm, body weight: 74.9 ± 8.7 kg, rel. VO2max: 56.7 ± 7.7 mL·kg−1·min−1; training hours/week: 10.3 ± 3.7 h) participated in this study. All participants abstained from alcohol consumption 24 h prior to and during the training intervention, were non-smokers and did not take medication regularly. No respiratory and cardiac abnormalities were determined in the pre-study medical examinations and none of the subjects reported of chronic diseases. All test persons were informed about the study contents and gave their written consent for participation in the examinations, diagnoses and blood drawings. The study protocol was approved by the ethical committee of the German Sport University Cologne and is in line with the Declaration of Helsinki.

2.2. Study Design

Each participant completed four cycling tests in a randomized order at intervals of one week on a SRM cycle ergometer (Schoberer, Jülich, Germany) under different conditions: (a) normal ambient conditions (sea levels); (b) three different normobaric hypoxic conditions (2000 m (FiO2 = 16.3%), 3000 m (FiO2 = 14.2%), 4000 m (FiO2 = 12.7%), respectively). Normobaric hypoxic conditions were generated using a hypoxic chamber (Hypoxico Inc., New York, USA). The VO2max, the maximal power output (Pmax) and the arterial oxygen saturation (SaO2) were measured during exercise.

2.3. Exercise Protocol

The VO2max test was held to an incremental exercise protocol (Figure 1). After taking the first venous blood samples the athletes carried out a 10 min warm-up program with an output of 70 Watts (W) with arbitrary pedaling frequency.
Starting with 100 W the output was increased every minute by 30 W until individual exhaustion. The exercise was aborted when the subjects were unable to perpetuate the given pedaling frequency of 70–80 round per minute (rpm) or if the test was discontinued due to individual exhaustion. The measurement of the spirometry data (MetaLyzer 3B, Cortex) began with the start of the incremental exercise. During all exercise procedures under the different ambient conditions, the SaO2 was measured (C3 Patients monitor, Philips GmbH, Hamburg, Germany) to determine the impact/severity of exercise and the respective simulated altitude.

2.4. Measurement of VEGF, MMP-2, MMP-9 and Endostatin Serum Levels

Venous blood samples were drawn at the following time points: pre-exercise, 10 min (min) post, 30 min post, 60 min post and 240 min post exercise (Figure 1). 9.5 mL of blood was collected with the EDTA containing Vacutainer® blood withdrawal system (Becton Dickinson, Franklin Lakes, NJ, USA). After storage at 7 °C for approximately 30 min, after which blood coagulation was finished, the blood samples were centrifuged for 10 min at 1861× g and 4° C (Rotixa 50, Hettich Zentrifugen, Mühlheim, Germany). The serum was stored at −80° C. Serum levels of VEGF (pg·mL−1), MMP-2 (ng·mL−1), MMP-9 (ng·mL−1) and endostatin (ng·mL−1) were determined by using human ELISA kits (R&D Systems, Wiesbaden, Germany).

2.5. Statistics

All data are listed as mean ± standard deviation. The statistical analyses were carried out by the use of STATISTICA for Windows, Version 7.1 (Statsoft, Tulsa, OK, USA). Statistical prerequisites (normal distribution, homogeneity of variance) were fulfilled. Dependent t-tests were applied to check significance between two test points. Differences between the four conditions were analyzed via analysis of variance (ANOVA) with repeated measurements and a Tukey post-hoc test. The level of significance was set at p < 0.05.

3. Results

3.1. Pmax and Relative VO2max

The mean maximal power (Pmax) decreased significantly during the three VO2max tests under hypoxic conditions compared to sea level values. The power declined at maximal workload from 367 ± 48 W (sea level) to 342 ± 42 W at 2000 m (−6.7%, p < 0.001), 325 ± 39 W at 3000 m (−11.4%, p < 0.001) and to 308 ± 41 W at an altitude of 4000 m (−16.1%, p < 0.001).
The mean values for the relative VO2max of the twelve subjects under sea level was 56.7 ± 7.7 mL·kg−1·min−1. As expected, during all tests under hypoxic conditions (2000 m: −14.8%, p < 0.001; 3000 m: −21.2% p < 0.001 and 4000 m: −24.9% p < 0.001) the VO2max decreased significantly compared to the pre-values at sea level.

3.2. SaO2

We observed a significant decrease of the SaO2 at maximal workload during all tests under hypoxic conditions compared to NN values. The values decreased from 94.5 ± 4.7% at sea level to 84.2 ± 7.2% at 2000 m (−10.3%, p < 0.001), 78.1 ± 7.8% at 3000 m (−16.4%, p < 0.001) and to 71.8 ± 8.7% at 4000 m (−22.7%, p < 0.001).

3.3. VEGF

The mean pre-values of VEGF of the twelve subjects did not differ significantly at the four testing conditions sea level, 2000 m, 3000 m and 4000 m. Solely at an altitude of 4000 m the VEGF level significantly increased at 10 min post exercise compared to the pre-value (<0.05, Figure 2).

3.4. MMP-2 and -9

We did not observe significant differences between the pre concentrations of MMP-2 at sea level and the hypoxic interventions. MMP-2 values at 240 min post exercise decreased significantly at 4000 m compared to pre-exercise (p < 0.05, Figure 3). We found significant increases between the pre-values of MMP-9 at sea level and the three altitude conditions. At 2000 m and 4000 m, the MMP-9-concentrations increased significantly at 240 min post exercise (p < 0.05, respectively). At 3000 m MMP-9 showed a tendency to increase (p = 0.051, Figure 4).

3.5. Endostatin

We did not find significant differences between the mean pre-values of endostatin at the four testing conditions sea level, 2000 m, 3000 m and 4000 m. Endostatin concentrations increased significantly 10 min post exercise after each interventions (p < 0.05 for all hypoxic conditions) compared to pre-values (Figure 5). At the three following points of measurement (30 min post, 60 min post, 240 min post exercise) the endostatin values declined to pre-level under all tested conditions sea level, 2000 m, 3000 m and 4000 m (Figure 5).

4. Discussion

Here, we demonstrate that regulations of exercise capacity-related angiogenic markers occur within a very short period upon acute exhaustion exercise under sea level as well as under the tested hypoxic conditions. Specifically, VEGF increased hypoxia-dependent at 10 min post exercise at 4000 m. MMP-2 did not show any acute response within a period of four hours post exercise under any tested conditions, whereas MMP-9 increased at four hours post-acute exhaustive exercise under 2000 m and 4000 m. Finally, the ECM-derived cleavage fragment endostatin increased at 10 min upon acute exhaustive exercise under each tested condition. These data demonstrate that acute exhaustive exercise initiates fast responses at the cytokine level to react to extreme changes provoked by such stimulations.
VEGF is one of the most potent angiogenic growth factor [12]. VEGF increases upon exercise [10,13,14]. Both mechanical forces (e.g., exercise) and hypoxia stimulate VEGF production and release. Hypoxia occurs locally in skeletal muscle tissue and can be enhanced by oxygen-reduced ambient conditions [15]. Mechanical stimuli increase as a result of enhanced blood flow during exhaustive exercise and subsequently elevate shear stress at the vessel walls [16,17].
In the present study, we observed a significant increase of the circulating VEGF concentrations at 10 min post exercise compared to the pre-value under hypoxic conditions at 4000 m. It is possible that a combination of exhaustive short-term exercise and severe hypoxic conditions (as reflected by the observed SaO2 values) represent a suitable combination to increase VEGF concentrations. The present results show tendencies similar to those found by Kraus et al. [14], who showed an up-regulation of VEGF in plasma directly and 120 min post exercise following a 60 min lasting exercise (50% Pmax). Suhr et al. [10] demonstrated a significant VEGF increase directly after 90 min of cycling exercise and concluded that mechanical rather than hypoxic stimuli control the VEGF increase. The exercise durations used in the studies of Kraus et al. [14] and Suhr et al. [10] lasted considerably longer than in the present study. This implies that the presently applied and discussed hypoxic conditions alone seem to be insufficient to induce releases of VEGF into the circulation (excepted 4000 m), but rather mechanical stimuli and exercise per se over a certain period may be responsible for VEGF releases. Finally, the presented data do not represent angiogenic processes per se. However, they demonstrate the potential of acute short-intense exercise to release angiogenesis-triggering molecules, e.g., VEGF, that might in combination with classical long-lasting endurance training result in sufficient angiogenic adaptations.
MMP-2 and MMP-9 contribute to angiogenic events through regulating the balance between pro- and anti-angiogenic factors [7]. MMP-2 and MMP-9 either inhibit angiogenesis by generating angiogenic modulators (e.g., endostatin) [18] or by stimulating angiogenesis by liberation of growth factors (e.g., VEGF) from the extracellular matrix [19]. Whereas MMP-2 appears to be involved in the stabilization and maturing of new capillaries, MMP-9 is attributed to the primary activation and stimulation of endothelial cells and thus the initiating proceedings in the formation of new capillaries [6].
We did not find any increases in MMP-2 levels until 240 min post exercise at any condition. Hence, our intervention was insufficient to increase MMP-2 levels within 240 min. In contrast, we found elevated MMP-9 levels at 240 min post exercise compared to the pre-value under 2000 m and 4000 m conditions. Under 3000 m the MMP-9 level tended to increase (p = 0.051). This finding shows that exercise elevates MMP-9 levels to contribute to angiogenic initiations during the first hours of activation.
Several studies showed exercise-induced increase of MMP-2 and MMP-9 [10,20,21]. Our former results [10] are partially in line with the present results as we found increased MMP-2 levels directly after different intensive cycling interventions and an increment of MMP-9 levels 240 min post exercise. Directly after 60 min of intensive uphill treadmill exercise Koskinen et al. [21] found an up-regulation of MMP-2 and MMP-9. The contrary running type—downhill running—increased MMP-9 significantly after a 45 min-lasting exercise bout [20]. The described partial differences between our present study and the discussed ones seem to be caused by different exercise modes and highly divergent exercise durations, which seem to be the major aspect, since in all studies both mechanical and (at least local) hypoxic stimuli were induced. Of note, MMP-9 is directly involved angiogenic remodeling [22]. Of course, the measured circulating MMP-9 levels do not immediately influence the angiogenic phenotype; however, MMP-9 molecules could adhere locally in the peripheral muscle tissue to act as angiogenesis-mediated compounds. The latter event will likely occur upon a long-lasting training intervention, but not after the presented short-intense exercise bout. Finally, it remains speculative until when the MMP-9 levels might remain elevated beyond the 4 h after cessation of exercise as measured in this study. Further studies that evaluate the time course of MMP-9 over a longer period, e.g., 24 h, upon a single short-intense exercise bout could contribute to the clarification of this relevant question.
Initially, endostatin was claimed as a potent angiogenesis inhibitors, as it retarded the VEGF-induced proliferation and migration of endothelial cells as well as enhanced their apoptosis [23,24]. However, recent approaches argue for the function of an angiogenesis modulator with both pro- and anti-angiogenic effects in a concentration-dependent mechanism of action [4,7,25]. However, the exact biological function of endostatin remains unknown [7,26].
Under the four conditions (sea level, 2000 m, 3000 m und 4000 m), endostatin concentrations increased significantly at 10 min post exercise compared to the pre-test and subsequently decreased at 30 min post, 60 min post and at 240 min post exercise to pre-level. Different investigations showed increasing endostatin concentrations after exercise [10,11,13,27]. The present results suggest that the exhaustive exercise tests might have stimulated the protein turnover of the connective tissue and therefore released endostatin as a fragment derived from collagen type XVIII, which is a highly abundant molecule of vascular basement membranes in skeletal muscles [28]. Our group [10] showed that endostatin values increased significantly immediately after 90 min of intensive cycling exercise under both normoxic and hypoxic conditions. In consensus to the present study, we [10] did not observe a potential influence of hypoxic stimuli on the endostatin release. In contrast, Paddenberg et al. [27] found increased endostatins level after a three weeks lasting hypoxic intervention in mice. The protocol of the Paddenberg study was not comparable to the present study with an intervention duration of 10 min and might therefore be responsible for the contrary results. The study of Gu et al. [13] is comparable with the present one regarding the intensity and duration of exercise. The authors found an increase of endostatin after a short-time intensive running exercise (4–10 min) under normoxic conditions. Interestingly, Wenzel and colleagues [4] demonstrated in vitro that endostatin evokes vascular relaxation by increasing nitric oxide demonstrating that endostatin may be a potent regulator of the peripheral vascular tone and may play a key role in the local oxygen supply in the periphery. That implies that physical exercise is an important factor to control peripheral blood flow and vascular tone. Our data reveal that single bouts of exhausting, but short cycling exercise can induce the protein turnover of the ECM independently of external applied hypoxia and therefore contribute to the local supply in the peripheral skeletal system.
Finally, we would like to discuss possible changes of oxidant/antioxidant as well as inflammatory aspects with respect to our study protocol, since these pathways (among others) might influence exercise-induced adaptations. Exercise and training influences both oxidant and antioxidant status of the human body. In this regards, it was demonstrated in rowers that acute exercise bouts elevated protein oxidation status [29]. A similar result was demonstrated in a study, in which professional cyclists performed a single as well as a series of Wingate tests [30]. In contrast, longer period training interventions under hypoxic conditions did not result in changes of protein oxidation status of middle distance runners and swimmers [31,32]. Interestingly, a study investigating the effect of hypoxic training demonstrated that the antioxidant status in participating elite cross-country skiers was still affected at 14 days after the end of the hypoxic intervention [33]. Summarized, these examples demonstrate that acute exercise might exert an effect on oxidant/antioxidant status, whereas hypoxia might influence this status rather upon longer period training interventions. Hence, it is reasonable to assume that our acute short-term intensive exercise interventions resulted in changes of the oxidant/antioxidant status of the participating athletes. In addition, intensive exercise can alter inflammatory markers. It was demonstrated that an acute intense 3000 m time trial resulted in a differentiated inflammatory marker response. Interleukin (IL)-1β, IL-6, myeloperoxidase (MPO) and macrophage colony-stimulating factor increased, whereas IL-4 and IL-10 decreased and tumor necrosis factor α, IL-2 and IL-8 did not change [34]. Similar results were reported after a duathlon race, which caused increased IL-6 and MPO [35]. Although we did not assess oxidant/antioxidant as well as inflammatory markers in this study, we emphasize their investigation in future studies that focus on angiogenesis-related research, since these markers are involved in the control of angiogenic processes [36,37].

5. Conclusions

The new finding of this study is that exhausting short-term cycling exercise reveals the potential to induce ECM protein turnover resulting in a significant generation of endostatin 10 min post exercise. Thus, the presented results may contribute to a broader understanding of exercise-induced remodeling processes in the ECM and subsequently induced release and activation of angiogenic biomarkers. Both exercise scientists and medical therapists can benefit from these results in combination with discussed ones on oxidant/antioxidant as well as inflammatory markers to develop new training strategies to enhance physical capacities or new medical therapies for patients suffering from cardiovascular diseases.

Author Contributions

Conceptualization, F.S., S.K. and M.d.M.; methodology, F.S., S.K., S.A. and M.d.M.; formal analysis, F.S. and S.K.; investigation, F.S., S.K. and M.d.M.; resources, J.M.; data curation, F.S. and S.K.; writing—original draft preparation, F.S.; writing—review and editing, F.S., S.K., S.A., J.M. and M.d.M.; visualization, F.S. and S.K.; project administration, F.S., J.M. and M.d.M. All authors have read and agreed to the published version of the manuscript.

Funding

This study was sponsored by the German Research Center of Elite Sport, German Sport University Cologne.

Institutional Review Board Statement

The study protocol was approved by the ethical committee of the German Sport University Cologne (the ethical code: 113/2021; the approved date: 14 July 2021) and is in line with the Declaration of Helsinki.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hargreaves, M. Skeletal muscle metabolism during exercise in humans. Clin. Exp. Pharmacol. Physiol. 2000, 27, 225–228. [Google Scholar] [CrossRef] [PubMed]
  2. Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 2005, 438, 932–936. [Google Scholar] [CrossRef] [PubMed]
  3. Prior, B.M.; Yang, H.T.; Terjung, R.L. What makes vessels grow with exercise training? J. Appl. Physiol. 2004, 97, 1119–1128. [Google Scholar] [CrossRef] [PubMed]
  4. Wenzel, D.; Schmidt, A.; Reimann, K.; Hescheler, J.; Pfitzer, G.; Bloch, W.; Fleischmann, B.K. Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ. Res. 2006, 98, 1203–1211. [Google Scholar] [CrossRef] [Green Version]
  5. Carmeliet, P.; Ferreira, V.; Breier, G.; Pollefeyt, S.; Kieckens, L.; Gertsenstein, M.; Fahrig, M.; Vandenhoeck, A.; Harpal, K.; Eberhardt, C.; et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nat. Cell Biol. 1996, 380, 435–439. [Google Scholar] [CrossRef]
  6. Kessenbrock, K.; Plaks, V.; Werb, Z. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell 2010, 141, 52–67. [Google Scholar] [CrossRef] [Green Version]
  7. Suhr, F.; Brixius, K.; Bloch, W. Angiogenic and vascular modulation by extracellular matrix cleavage products. Curr. Pharm. Des. 2009, 15, 389–410. [Google Scholar] [CrossRef]
  8. Hynes, R.O. The extracellular matrix: Not just pretty fibrils. Science 2009, 326, 1216–1219. [Google Scholar] [CrossRef] [Green Version]
  9. Faye, C.; Chautard, E.; Olsen, B.R.; Ricard-Blum, S. The first draft of the endostatin interaction network. J. Biol. Chem. 2009, 284, 22041–22047. [Google Scholar] [CrossRef] [Green Version]
  10. Suhr, F.; Brixius, K.; De Marées, M.; Bölck, B.; Kleinöder, H.; Achtzehn, S.; Bloch, W.; Mester, J. Effects of short-term vibration and hypoxia during high-intensity cycling exercise on circulating levels of angiogenic regulators in humans. J. Appl. Physiol. 2007, 103, 474–483. [Google Scholar] [CrossRef]
  11. Suhr, F.; Rosenwick, C.; Vassiliadis, A.; Bloch, W.; Brixius, K. Regulation of extracellular matrix compounds involved in angiogenic processes in short- and long-track elite runners. Scand. J. Med. Sci. Sports 2009, 20, 441–448. [Google Scholar] [CrossRef]
  12. Ferrara, N.; Gerber, H.-P.; LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 2003, 9, 669–676. [Google Scholar] [CrossRef] [PubMed]
  13. Gu, J.-W.; Gadonski, G.; Wang, J.; Makey, I.; Adair, T.H. Exercise increases endostatin in circulation of healthy volunteers. BMC Physiol. 2004, 4, 2. [Google Scholar] [CrossRef] [Green Version]
  14. Kraus, R.M.; Stallings, H.W.; Yeager, R.C.; Gavin, T.P. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J. Appl. Physiol. 2004, 96, 1445–1450. [Google Scholar] [CrossRef]
  15. Birot, O.J.G.; Koulmann, N.; Peinnequin, A.; Bigard, X.A. Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J. Physiol. 2003, 552, 213–221. [Google Scholar] [CrossRef]
  16. Brown, M.; Hudlicka, O. Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: Involvement of VEGF and metalloproteinases. Angiogenesis 2003, 6, 1–14. [Google Scholar] [CrossRef] [PubMed]
  17. Yue, Z.; Mester, J. A model analysis of internal loads, energetics, and effects of wobbling mass during the whole-body vibration. J. Biomech. 2002, 35, 639–647. [Google Scholar] [CrossRef]
  18. Berceli, S.A.; Jiang, Z.; Klingman, N.V.; Schultz, G.S.; Ozaki, C.K. Early Differential MMP-2 and -9 Dynamics During Flow-Induced Arterial and Vein Graft Adaptations. J. Surg. Res. 2006, 134, 327–334. [Google Scholar] [CrossRef] [PubMed]
  19. Zatterstrom, U.K.; Felbor, U.; Fukai, N.; Olsen, B.R. Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct. Funct. 2000, 25, 97–101. [Google Scholar] [CrossRef] [Green Version]
  20. Koskinen, S.O.A.; Hoyhtya, M.; Turpeenniemi-Hujanen, T.; Martikkala, V.; Makinen, T.T.; Oksa, J.; Rintamaki, H.; Lofberg, M.; Somer, H.; Takala, T.E.S. Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running. Scand. J. Med. Sci. Sports 2001, 11, 9–15. [Google Scholar] [CrossRef]
  21. Koskinen, S.O.A.; Heinemeier, K.M.; Olesen, J.L.; Langberg, H.; Kjaer, M. Physical exercise can influence local levels of matrix metalloproteinases and their inhibitors in tendon-related connective tissue. J. Appl. Physiol. 2004, 96, 861–864. [Google Scholar] [CrossRef] [Green Version]
  22. Bergers, G.; Brekken, R.; McMahon, G.; Vu, T.H.; Itoh, T.; Tamaki, K.; Tanzawa, K.; Thorpe, P.; Itohara, S.; Werb, Z.; et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2, 737–744. [Google Scholar] [CrossRef]
  23. Bloch, W.; Huggel, K.; Sasaki, T.; Grose, R.; Bugnon, P.; Addicks, K.; Timpl, R.; Werner, S. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J. 2000, 14, 2373–2376. [Google Scholar] [CrossRef]
  24. Pufe, T.; Petersen, W.J.; Miosge, N.; Goldring, M.B.; Mentlein, R.; Varoga, D.J.; Tillmann, B.N. Endostatin/collagen XVIII—An inhibitor of angiogenesis—Is expressed in cartilage and fibrocartilage. Matrix Biol. 2004, 23, 267–276. [Google Scholar] [CrossRef] [PubMed]
  25. Schmidt, A.; Addicks, K.; Bloch, W. Opposite effects of endostatin on different endothelial cells. Cancer Biol. Ther. 2004, 3, 1162–1166. [Google Scholar] [CrossRef] [Green Version]
  26. Wickström, S.A.; Alitalo, K.; Keski-Oja, J. Endostatin signaling and regulation of endothelial cell-matrix interactions. Adv. Cancer Res. 2005, 94, 197–229. [Google Scholar] [CrossRef]
  27. Paddenberg, R.; Faulhammer, P.; Goldenberg, A.; Kummer, W. Hypoxia-induced increase of endostatin in murine aorta and lung. Histochem. Cell Biol. 2006, 125, 497–508. [Google Scholar] [CrossRef]
  28. Timpl, R. Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 1996, 8, 618–624. [Google Scholar] [CrossRef]
  29. Kyparos, A.; Riganas, C.; Nikolaidis, M.G.; Sampanis, M.; Koskolou, M.D.; Grivas, G.; Kouretas, D.; Vrabas, I.S. The effect of exercise-induced hypoxemia on blood redox status in well-trained rowers. Graefe’s Arch. Clin. Exp. Ophthalmol. 2011, 112, 2073–2083. [Google Scholar] [CrossRef] [PubMed]
  30. Cuevas, M.J.; Almar, M.; García-Glez, J.C.; García-López, D.; De Paz, J.A.; Alvear-Ordenes, I.; González-Gallego, J. Changes in oxidative stress markers and NF-κB activation induced by sprint exercise. Free Radic. Res. 2005, 39, 431–439. [Google Scholar] [CrossRef]
  31. Pialoux, V.; Mounier, R.; Rock, E.; Mazur, A.; Schmitt, L.; Richalet, J.-P.; Robach, P.; Brugniaux, J.; Coudert, J.F.; Fellmann, N. Effects of the “live high-train low” method on prooxidant/antioxidant balance on elite athletes. Eur. J. Clin. Nutr. 2008, 63, 756–762. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Pialoux, V.; Mounier, R.; Brugniaux, J.V.; Rock, E.; Mazur, A.; Richalet, J.-P.; Robach, P.; Coudert, J.; Fellmann, N. Thirteen days of “live high-train low” does not affect prooxidant/antioxidant balance in elite swimmers. Eur. J. Appl. Physiol. 2009, 106, 517–524. [Google Scholar] [CrossRef] [PubMed]
  33. Pialoux, V.; Brugniaux, J.; Rock, E.; Mazur, A.; Schmitt, L.; Richalet, J.-P.; Robach, P.; Clottes, E.; Coudert, J.; Fellmann, N.; et al. Antioxidant status of elite athletes remains impaired 2 weeks after a simulated altitude training camp. Eur. J. Nutr. 2010, 49, 285–292. [Google Scholar] [CrossRef]
  34. Tominaga, T.; Ma, S.; Sugama, K.; Kanda, K.; Omae, C.; Choi, W.; Hashimoto, S.; Aoyama, K.; Yoshikai, Y.; Suzuki, K. Changes in urinary biomarkers of organ damage, inflammation, oxidative stress, and bone turnover following a 3000-m time trial. Antioxidants 2021, 10, 79. [Google Scholar] [CrossRef]
  35. Sugama, K.; Suzuki, K.; Yoshitani, K.; Shiraishi, K.; Miura, S.; Yoshioka, H.; Mori, Y.; Kometani, T. Changes of thioredoxin, oxidative stress markers, inflammation and muscle/renal damage following intensive endurance exercise. Exerc. Immunol. Rev. 2015, 21, 130–142. [Google Scholar] [PubMed]
  36. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nat. Cell Biol. 2008, 454, 436–444. [Google Scholar] [CrossRef]
  37. Schröder, K. Redox Control of Angiogenesis. Antioxidants Redox Signal. 2019, 30, 960–971. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Exercise protocol. * = venous blood samples.
Figure 1. Exercise protocol. * = venous blood samples.
Medicina 57 00727 g001
Figure 2. VEGF (vascular endothelial growth factor) concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * = p < 0.05 to pre.
Figure 2. VEGF (vascular endothelial growth factor) concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * = p < 0.05 to pre.
Medicina 57 00727 g002
Figure 3. MMP-2 concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * p < 0.05 to pre.
Figure 3. MMP-2 concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * p < 0.05 to pre.
Medicina 57 00727 g003
Figure 4. MMP-9 concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * p < 0.05 to pre.
Figure 4. MMP-9 concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * p < 0.05 to pre.
Medicina 57 00727 g004
Figure 5. Endostatin concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * p < 0.05 to pre.
Figure 5. Endostatin concentration at the five measurement time points (pre, 10 min post, 30 min post, 60 min post, 240 min post exercise) during the different ambient conditions (sea level, 2000 m, 3000 m, 4000 m). Mean ± standard deviation. * p < 0.05 to pre.
Medicina 57 00727 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Suhr, F.; Knuth, S.; Achtzehn, S.; Mester, J.; de Marees, M. Acute Exhaustive Exercise under Normoxic and Normobaric Hypoxic Conditions Differentially Regulates Angiogenic Biomarkers in Humans. Medicina 2021, 57, 727. https://doi.org/10.3390/medicina57070727

AMA Style

Suhr F, Knuth S, Achtzehn S, Mester J, de Marees M. Acute Exhaustive Exercise under Normoxic and Normobaric Hypoxic Conditions Differentially Regulates Angiogenic Biomarkers in Humans. Medicina. 2021; 57(7):727. https://doi.org/10.3390/medicina57070727

Chicago/Turabian Style

Suhr, Frank, Sarah Knuth, Silvia Achtzehn, Joachim Mester, and Markus de Marees. 2021. "Acute Exhaustive Exercise under Normoxic and Normobaric Hypoxic Conditions Differentially Regulates Angiogenic Biomarkers in Humans" Medicina 57, no. 7: 727. https://doi.org/10.3390/medicina57070727

APA Style

Suhr, F., Knuth, S., Achtzehn, S., Mester, J., & de Marees, M. (2021). Acute Exhaustive Exercise under Normoxic and Normobaric Hypoxic Conditions Differentially Regulates Angiogenic Biomarkers in Humans. Medicina, 57(7), 727. https://doi.org/10.3390/medicina57070727

Article Metrics

Back to TopTop